BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats

Table 1

Characteristics of study animals.

	Body weight (grams ± SEM)		Glucose (mg/dL ± SEM)
	Start	12 wks diabetes/8 wks treatment	Start	1 wk diabetes	12 wks diabetes/8 wks treatment
Control nondiabetic	273 ± 33	589 ± 15	107 ± 3	108 ± 5	137 ± 23
Diabetic vehicle-treated	273 ± 20	446 ± 18	115 ± 6	352 ± 36	375 ± 36
Diabetic antibody-treated	270 ± 21	425 ± 23	113 ± 7	414 ± 25	425 ± 28

= 15 for each group.